Radius Health Inc. (RDUS)

26.09
1.04 4.15
NASDAQ : Health Technology
Prev Close 25.05
Open 25.06
Day Low/High 25.05 / 26.24
52 Wk Low/High 12.81 / 29.97
Volume 430.21K
Avg Volume 544.90K
Exchange NASDAQ
Shares Outstanding 46.12M
Market Cap 1.13B
EPS -4.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Biotech Moves Are Anything But Crazy

New companies are coming up with major drugs.

'Mad Money' Lightning Round: Buy, Buy, Buy Yahoo!, Not Alibaba

'Mad Money' Lightning Round: Buy, Buy, Buy Yahoo!, Not Alibaba

Cramer is taking a pass on Petrobras and is still on the fence about Gogo.

Jim Cramer's 'Mad Money' Recap: 'Hit and Run' Investors Are the Worst

Jim Cramer's 'Mad Money' Recap: 'Hit and Run' Investors Are the Worst

Don't buy into the panic, only buy stocks you understand and are willing to hold onto for the long term, Cramer says.

3 Biotechs That Are Worth Buying

Many of these stocks are off to the races.

Cramer: I Like Receptos and Radius, as Well as the Four Horsemen

Cramer: I Like Receptos and Radius, as Well as the Four Horsemen

Jim Cramer answers viewers' stock questions from the floor of the New York Stock Exchange.

The Top 5 Best IPO Performers in the Last Year

The Top 5 Best IPO Performers in the Last Year

These are the top five best IPO performers in the last 12 months.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

Short Interest In Radius Health Jumps 30.8%

Short Interest In Radius Health Jumps 30.8%

The most recent short interest data has been released by the NASDAQ for the 02/13/2015 settlement date, which shows a 295,549 share increase in total short interest for Radius Health Inc , to 1,254,050, an increase of 30.83% since 01/30/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Biotechs and Drugmakers Expected to Seek More Mergers in 2015

Biotechs and Drugmakers Expected to Seek More Mergers in 2015

The perceived risk from macroeconomic issues — such as those in Europe — as well as changes in both interest rates and oil prices will make outright sales more attractive.

14 IPOs You Wish You Bought in 2014 (and Made a Killing On)

14 IPOs You Wish You Bought in 2014 (and Made a Killing On)

Getting in on a hot IPO may prove difficult for most retail investors. That doesn't mean there aren't gains to be made. Here are the best performing IPOs in 2014.

Jim Cramer's Top Stock Picks: BA MCD FB CLB RDUS

Jim Cramer's Top Stock Picks: BA MCD FB CLB RDUS

Cramer says Boeing continues to benefit from low oil prices and everything Facebook touches turns to gold

Jim Cramer's 'Mad Money' Recap: The Bears Retreat and the Market Celebrates

Jim Cramer's 'Mad Money' Recap: The Bears Retreat and the Market Celebrates

Today was a terrific snap-back rally, a day when the bears retreated and calmer heads could take advantage of all the positives that go unappreciated on most days, Cramer says.

TheStreet Quant Rating: D- (Sell)